Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model

被引：121

作者：

Tamura R. ^{[1
]}

Uemoto S. ^{[2
]}

Tabata Y. ^{[1
]}

机构：

[1] Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto

[2] Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto

来源：

Inflammation and Regeneration | / 36卷 / 1期

关键词：

Concavanalin-A; Exosome; Immune-induced liver injury; Mesenchymal stem cell; Nanovesicle; Transplantation;

D O I：

10.1186/s41232-016-0030-5

中图分类号：

学科分类号：

摘要：

Background: This study aimed to evaluate the effect of mesenchymal stem cell (MSC)-derived exosomes on an immune-induced liver injury model. MSCs show a unique function to modulate immune reaction although the molecular mechanisms are still under investigation. Exosomes are a nanoparticle containing microRNA and many ligands and are recognized as important factors secreted from MSC to express their function. This research is undertaken to evaluate the effect of MSC-derived exosome on concanavalin-A (con-A)-induced liver injury. Methods: Exosomes were collected from the supernatant of MSC from the bone marrow of C57B6 mice with ultracentrifugation. The collected exosomes or MSCs were injected intravenously into liver injury mice that had been prepared by the intravenous con-A injection. Liver and serum samples were collected 24 h later to evaluate the macro- and microscopic images, the alanine aminotransferase (ALT), and cytokine messenger RNA (mRNA) expression levels. Phenotypical change of non-parenchymal liver cells was also evaluated by flow cytometry. Liver localization of PKH26 after the injection of PKH26-labeled exosomes or MSCs was observed by microscope. Each result was statistically analyzed with Student’s t test. Results: PKH was observed in the liver after PKH-labeled exosomes were injected into mouse, whereas it was only observed in the lung in a mouse group receiving PKH-leveled MSC. There were decreases in ALT, liver necrotic areas, and the extent of apoptosis indicated by the single-stranded DNA index of groups that received multiple injections of MSC-derived exosomes, but an increase in the Ki-67 index. The mRNA expression of anti-inflammatory cytokines was enhanced. The number of Treg was increased among NPCs in a group receiving exosomes multiple times. Conclusions: Suppression of con-A-induced liver injury by injection of exosomes was observed as same extent as MSC. Considering the advantage of exosomes as its non-living nature and dosing adjustability over MSC, exosome will be one alternative of MSC transplantation. © The Author(s).

引用

共 48 条

[1]

Freidenstein A., Chailakhyan R., Latsinik N., Panasyuk A., Keiliss-Borok I., Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues, Transplantation, 17, (1974)

[2]

Petite H., Viateau V., Bensaid W., Meunier A., De Pollak C., Bourguignon M., Oudina K., Sedel L., Guillemin G., Tissue-engineered bone regeneration, Nat Biotechnol, 18, pp. 959-963, (2000)

[3]

Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Quinn G., Okochi H., Ochiya T., Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes, Hepatology, 46, pp. 219-228, (2007)

[4]

Duncan A.W., Dorrell C., Grompe M., Stem cells and liver regeneration, Gastroenterology, 137, pp. 466-481, (2009)

[5]

Kanazawa H., Fujimoto Y., Teratani T., Iwasaki J., Kasahara N., Negishi K., Tsuruyama T., Uemoto S., Kobayashi E., Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model, Plos One, 6, (2011)

[6]

Aggarwal S., Pittenger M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, pp. 1815-1822, (2005)

[7]

Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Et al., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study, Lancet, 371, pp. 1579-1586, (2008)

[8]

Hoogduijn M.J., Popp F.C., Grohnert A., Crop M.J., Van Rhijn M., Rowshani A.T., Eggenhofer E., Renner P., Reinders M.E., Rabelink T.J., Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT), Transplantation, 90, pp. 124-126, (2010)

[9]

Casiraghi F., Perico N., Remuzzi G., Mesenchymal stromal cells to promote solid organ transplantation tolerance, Curr Opin Organ Transplant, 18, pp. 51-58, (2013)

[10]

Van Poll D., Parekkadan B., Cho C.H., Berthiaume F., Nahmias Y., Tilles A.W., Yarmush M.L., Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo, Hepatology, 47, pp. 1634-1643, (2008)

← 1 2 3 4 5 →